Europe and MEA Culture Test for Healthcare-associated Infections Market

Q: What will be the CAGR of the Europe and MEA culture test for healthcare-associated infections industry during the forecast period?

The CAGR is anticipated to be 2.9% from 2024 to 2034. Read More

Europe and MEA Culture Test for Healthcare-associated Infections Market (Product: Instruments, Reagents and Consumables; Test Type: Escherichia coli infection, Staphylococcus aureus infection, Enterococcus species infection, Pseudomonas aeruginosa infection, Clostridium difficile infection, Enterobacter Species and Others; Target Area: Bloodstream, Urinary Tract, Surgical Site, Gastrointestinal, Respiratory and Others) - Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2034

Report Preview
Table of Content

Europe and MEA Culture Test for Healthcare-associated Infections Market Outlook 2034

Europe and Middle-East & Africa industry was valued at US$ 270.3 Mn in 2023
It is projected to advance at a CAGR of 2.9% from 2024 to 2034 and reach more than US$ 371.3 Mn by the end of 2034

Analyst Viewpoint Regarding Europe and MEA Culture Test for Healthcare-associated Infections Market

The increasing incidence of infections acquired in healthcare settings has prompted a growing emphasis on culture tests as essential diagnostic tools. With the growing volume of surgical procedures and hospital admissions across Europe and the MEA region, the risk of healthcare-associated infections also rises, leading to higher morbidity, mortality as well as healthcare costs. This alarming trend has necessitated policymakers to put infection prevention and control strategies into practice at healthcare settings.

Further, heightened awareness among healthcare practitioners regarding the need of infection control measures has fueled the demand for culture tests for healthcare-associated infections (HAIs). Additionally, organizations such as the Centers for Disease Control and Prevention (CDC) and the World Health Organization (WHO) advocate for routine screening and monitoring of infections through circulation of stringent regulatory mandates and guidelines, further driving the demand for effective culture testing methods, contributing toward Europe and MEA culture test for HAIs market expansion.

There have been notable advancements in culture testing techniques over the past decades, contributing to Europe and MEA culture test for Healthcare-associated infections market expansion through enhancing the speed and accuracy of infection identification.

Moreover, these innovations enable expedited clinical decisions and lead to improved patient outcomes by allowing accurate treatment interventions. As healthcare facilities strive to meet quality improvement initiatives and accreditation standards, the adoption of culture tests for HAIs is poised to escalate, bolstering market growth.

Europe and MEA Culture Test for Healthcare-associated Infections Market Outlook

Healthcare-associated infections (HAIs) are infections that patients acquire while receiving medical treatment for the other conditions within healthcare settings such as hospitals, nursing homes, and outpatient clinics. Surgical site infections, bloodstream infections, urinary tract infections, and pneumonia are some of the various forms of HAIs. Several pathogens are responsible for these infections including Staphylococcus aureus, Escherichia coli, and Clostridium difficile, among others.

Patient safety and healthcare quality are gravely threatened by the incidence of HAIs, which raises rates of morbidity and mortality, lengthens hospital stays, and raises healthcare expenses. Culture testing is a critical diagnostic tool for management and prevention of HAIs.

This diagnostic method allows healthcare providers to pinpoint the precise pathogen causing illnesses and also ascertain their susceptibility to antibiotics, allowing for more focused and effective therapy. Additionally, through culture testing, infection trends can be studied accurately, in turn, aiding infection control practices, and devising public health strategies.

Attribute	Detail
Europe and MEA Culture Test for Healthcare-associated Infections Market Drivers	Increasing Prevalence of Healthcare-associated Infections Rising Awareness and Adoption of Infection Control Measures

Increasing Prevalence of Healthcare-associated Infections Boosting Europe and MEA Culture Test for Healthcare-associated Infections Market

The increasing prevalence of HAIs is significantly influencing the growth of the Europe and the Middle East and Africa culture test for healthcare-associated infections market over the forecast period. HAIs, such as hospital-acquired pneumonia (HAP), surgical site infections (SSIs), and bloodstream infections (BSIs), pose significant threat for healthcare facilities, as they lead to increased morbidity, mortality, and healthcare costs.

For instance, according to data published by European Centre for Disease Prevention and Control (ECDC) in May 2024, 4.3 million patients in hospitals in the EU/EEA acquire at least one healthcare-associated infection during their stay in the hospital each year.

With the rise in aging population and the ongoing surge in the prevalence of chronic diseases, more patients are seeking medical care, leading to an increased rate of hospital admissions. This rise in patient turnover heightens the risk of HAIs, as more individuals receive invasive procedures and treatments in healthcare settings.

The complexity of care is increased by developments in medical technology and treatment options, including immunosuppressive medicines and operations. Although these advancements have the potential to save lives, they also increase the danger of infection, especially for susceptible patient groups.

Rising Awareness and Adoption of Infection Control Measures Driving Growth of Europe and MEA Culture Test for Healthcare-associated Infections Market

Increasing awareness and adoption of infection control measures is expected to drive the Europe and MEA culture test for healthcare-associated infections market over the forecast period. With the rising awareness among healthcare providers and patients regarding the risks associated with HAIs, they are increasingly adopting infection control measures to prevent and control such infections.

This growing awareness is driving the demand for culture tests, which are a critical component of infection control measures. In order to take swift and targeted actions to prevent the spread of HAIs, healthcare professionals utilize culture tests to identify and track infections. As a result, the market for culture tests for identifying HAIs is expected to experience significant growth, driven by the increasing demand for effective infection control measures.

Governments and health authorities in Europe and the MEA are introducing stringent regulations aimed at reducing HAIs. In order to comply with these regulations, healthcare settings are often required to adopt culture testing as part of infection control protocols, further propelling Europe and MEA culture test for healthcare-associated infections market growth.

Further, collaborations between healthcare organizations, governmental bodies, and international health agencies in Europe and the MEA has fostered the sharing of best practices and resources for infection control. These initiatives promote the adoption of culture testing as a standard practice in infection management.

High Demand for Reagents and Consumables

Europe and MEA culture test for healthcare-associated infections market segmentation based on product includes instruments, and reagents and consumables.

The Reagents and Consumables segment accounts for largest revenue share in the Culture Test for Healthcare-associated Infections Market primarily as these products are used in every culture test, leading to constant replenishment and higher overall demand.

Instruments, on the other hand, are typically purchased less frequently. Additionally, compared to instruments, reagents and consumables demand a smaller initial expenditure. This increases sales volumes by making products more affordable for smaller labs and medical establishments.

Escherichia coli infection Driving Europe and MEA Culture Test for Healthcare-associated Infections Market Statistics

According to Europe and MEA culture test for healthcare-associated infections market industry report, based on test type, the market is classified into Escherichia coli infection, Staphylococcus aureus infection, Enterococcus species infection, Pseudomonas aeruginosa infection, Clostridioides diffcile infection, Enterobacter Species and Others. The Escherichia coli infection segment dominates the market.

It is important to note that E. coli is one of the most frequently isolated pathogens in healthcare-associated infections, particularly in urinary tract infections (UTIs) and gastrointestinal illnesses. Its widespread occurrence leads to a higher demand for testing.

Numerous illnesses, such as gastroenteritis, bloodstream infections, and UTIs, can be brought on by E. coli. The necessity for cultural testing in various healthcare settings is increased by this diversity. Additionally, the rise of antibiotic-resistant strains of E. coli, such as extended-spectrum beta-lactamase (ESBL) producing strains, has heightened the need for accurate culture tests to guide effective treatment options.

Regional Outlook of Europe and MEA Culture Test for Healthcare-associated Infections Industry

Attribute	Detail
Leading Region	Europe

According to the latest Europe and MEA Culture Test for Healthcare-associated Infections Market analysis, Europe held dominant share in 2023. The market expansion is driven by factors such as aging population and increased volume of surgical procedures. This has heightened the demand for effective diagnostic tools for identification of HAIs, including culture tests.

The market growth is driven by factors such as strict enforcement of infection control rules and policies by the European regulatory agencies that highlight the significance of precise diagnostic testing for the management of HAIs.

Within Europe, Germany emerged as the largest market for culture tests for HAIs industry. This can be attributed to Germany’s highly developed healthcare system with state-of-the-art hospitals, laboratories, and healthcare facilities. This infrastructure enables the implementation of advanced diagnostic technologies, including culture tests for HAIs.

Further, organizations like the Robert Koch Institute, the German federal authority for public health and infectious diseases, enforce Germany's stringent laws and policies for patient safety and infection control. The use of reliable diagnostic instruments, such as culture tests, is required to comply with these regulations.

Analysis of Key Players in Europe and MEA Culture Test for Healthcare-associated Infections Market

As culture test for HAI providers are constantly innovating to improve product capabilities, innovative technologies are being introduced for better efficacy.

Abbott Laboratories, Merck KGA, Becton Dickinson and Company, Steris Plc, Hologic, Inc., bioMerieux SA, F. Hoffmann-La Roche AG, Siemens Healthineers AG, Thermo Fisher Scientific Inc., Hardy Diagnostics, Bio-Rad Laboratories, Inc., Danaher Corporation, and SSI Diagnostica A/S are the prominent culture test for HAIs market players.

Key Developments in Europe and MEA Culture Test for Healthcare-associated Infections Market

In July 2024, Midmark Corporation launched its next-generation M11 and M9 steam sterilizers, designed for enhanced durability & ease of use. These sterilizers feature integrated capabilities to improve instrument processing and compliance documentation efficiencies.
In July 2023, Merck expanded its facility in Lenexa, Kansas, US to become the largest dry powder cell culture media facility and Center of Excellence in North America. The expansion will add 9,100 sq meters of lab space and production capability to manufacture cell culture media, an essential raw material used in life-saving therapies and biomanufacturing processes. The investment is poised to increase local and global production capacity to meet current demand and ensure a robust supply for future demand surges. Merck has three Centers of Excellence for dry powder cell culture media manufacturing, serving the Americas, Asia Pacific, and Europe, Middle East, and Africa regions.
In June 2023, MMM Group and Southwest Clinic jointly established a new CSSD/RUMED facility at the Calw clinic site on Robert-Bosch-Straße 13. This state-of-the-art facility handles the reprocessing of medical products, including Critical C-level items, for four clinics.

Each of these players has been have been profiled in the Europe and MEA Culture Test for Healthcare-associated Infections Market research report based on parameters such as company overview, financial overview, business strategies, product portfolio, business segments, and recent developments.

Europe and MEA Culture Test for Healthcare-associated Infections Market Snapshot

Attribute	Detail
Size in 2023	US$ 270.3 Mn
Forecast Value in 2034	More than US$ 371.3 Mn
CAGR	2.9%
Forecast Period	2024-2034
Historical Data Available for	2020-2023
Quantitative Units	US$ Mn for Value Thousand Units for Volume
Market Analysis	It includes segment analysis as well as regional level analysis. Moreover, qualitative analysis includes drivers, restraints, opportunities, key trends, value chain analysis, and key trend analysis.
Competition Landscape	Competition Matrix Company profiles section includes overview, product portfolio, sales footprint, key subsidiaries or distributors, strategy & recent developments, and key financials
Format	Electronic (PDF) + Excel
Segmentation	Product Instruments Reagents and Consumables Test Type Escherichia coli infection Staphylococcus aureus infection Enterococcus species infection Pseudomonas aeruginosa infection Clostridium diffcile infection Enterobacter Species Others Target Area Bloodstream Urinary Tract Surgical Site Gastrointestinal Respiratory Others Sample Type Blood Urine Stool Tissue Others End-user Hospitals & Clinics Nursing Homes Ambulatory Surgical Centers Others
Regions Covered	Europe Middle East and Africa
Countries Covered	Germany U.K. France Italy Spain Switzerland Netherlands Rest of Europe Saudi Arabia UAE South Africa Turkey Egypt Israel Rest of MEA
Companies Profiled	Abbott Laboratories Merck KGA Becton Dickinson and Company Steris Plc Hologic, Inc. bioMerieux SA F. Hoffmann-La Roche AG Siemens Healthineers AG Thermo Fisher Scientific Inc. Hardy Diagnostics Bio-Rad Laboratories, Inc. Danaher Corporation SSI Diagnostica A/S
Customization Scope	Available upon request
Pricing	Available upon request

Frequently Asked Questions

How big was the Europe and MEA culture test for healthcare-associated infections market in 2023?

Europe and MEA culture test for healthcare-associated infections market was valued at US$ 270.3 Mn in 2023.

How big will the Europe and MEA culture test for healthcare-associated infections business be in 2034?

Europe and MEA culture test for healthcare-associated infections market is projected to reach more than US$ 371.3 Mn by the end of 2034.

What will be the CAGR of the Europe and MEA culture test for healthcare-associated infections industry during the forecast period?

The CAGR is anticipated to be 2.9% from 2024 to 2034.

Who are the prominent Europe and MEA culture test for healthcare-associated infections providers?

1. Preface

1.1. Market Definition and Scope

1.2. Market Segmentation

1.3. Key Research Objectives

1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Europe and MEA Culture Test for Healthcare-associated Infections Market

4. Market Overview

4.1. Introduction

4.1.1. Segment Definition

4.2. Overview

4.3. Market Dynamics

4.3.1. Drivers

4.3.2. Restraints

4.3.3. Opportunities

4.4. Europe and MEA Culture Test for Healthcare-associated Infections Market Analysis and Forecast, 2020-2034

4.4.1. Market Revenue Projections (US$ Mn)

4.4.2. Market Volume/Unit Shipments Projections

5. Key Insights

5.1. Key Industry Events

5.2. Epidemiology of Diseases by Key Countries

5.3. Pricing Trend by Test Type

5.4. Insights on Inter-professional Approach to Healthcare-Associated Infections

5.5. Overview- Healthcare Associated Infections

5.6. Classification and characterization of HAI according to type

5.7. Representation of the most common isolated bacteria responsible for HAI

5.8. PEST Analysis

5.9. Regulatory Scenario by Key Countries/Regions

5.10. PORTER's Five Forces Analysis

5.11. Unmet Needs of the Market

6. Europe and MEA Culture Test for Healthcare-associated Infections Market Analysis and Forecast, by Product

6.1. Introduction & Definition

6.2. Key Findings/Developments

6.3. Market Value Forecast, by Product, 2020-2034

6.3.1. Instruments

6.3.2. Reagents and Consumables

6.4. Market Attractiveness Analysis, by Product

7. Europe and MEA Culture Test for Healthcare-associated Infections Market Analysis and Forecast, by Test Type

7.1. Introduction & Definition

7.2. Key Findings/Developments

7.3. Market Value & Volume Forecast, by Test Type, 2020-2034

7.3.1. Escherichia coli infection

7.3.2. Staphylococcus aureus infection

7.3.3. Enterococcus species infection

7.3.4. Pseudomonas aeruginosa infection

7.3.5. Clostridioides difficile infection

7.3.6. Enterobacter Species

7.3.7. Others

7.4. Market Attractiveness Analysis, by Test Type

8. Europe and MEA Culture Test for Healthcare-associated Infections Market Analysis and Forecast, by Target Area

8.1. Introduction & Definition

8.2. Key Findings/Developments

8.3. Market Value Forecast, by Target Area, 2020-2034

8.3.1. Bloodstream

8.3.2. Urinary Tract

8.3.3. Surgical Site

8.3.4. Gastrointestinal

8.3.5. Respiratory

8.3.6. Others

8.4. Market Attractiveness Analysis, by Target Area

9. Europe and MEA Culture Test for Healthcare-associated Infections Market Analysis and Forecast, by Sample Type

9.1. Introduction & Definition

9.2. Key Findings/Developments

9.3. Market Value Forecast, by Sample Type, 2020-2034

9.3.1. Blood

9.3.2. Urine

9.3.3. Stool

9.3.4. Tissue

9.3.5. Others

9.4. Market Attractiveness Analysis, by Sample Type

10. Europe and MEA Culture Test for Healthcare-associated Infections Market Analysis and Forecast, by End-user

10.1. Introduction & Definition

10.2. Key Findings/Developments

10.3. Market Value Forecast, by End-user, 2020-2034

10.3.1. Hospitals & Clinics

10.3.2. Nursing Homes

10.3.3. Ambulatory Surgical Centers

10.3.4. Others

10.4. Market Attractiveness Analysis, by End-user

11. Europe and MEA Culture Test for Healthcare-associated Infections Market Analysis and Forecast, by Region

11.1. Key Findings

11.2. Market Value Forecast, by Region, 2020-2034

11.2.1. Europe

11.2.2. MEA

11.3. Market Attractiveness Analysis, by Region

12. Europe Culture Test for Healthcare-associated Infections Market Analysis and Forecast

12.1. Introduction

12.1.1. Key Findings

12.2. Market Value Forecast, by Product, 2020-2034

12.2.1. Instruments

12.2.2. Reagents and Consumables

12.3. Market Value & Volume Forecast, by Test Type, 2020-2034

12.3.1. Escherichia coli infection

12.3.2. Staphylococcus aureus infection

12.3.3. Enterococcus species infection

12.3.4. Pseudomonas aeruginosa infection

12.3.5. Clostridioides difficile infection

12.3.6. Enterobacter Species

12.3.7. Others

12.4. Market Value Forecast, by Target Area, 2020-2034

12.4.1. Bloodstream

12.4.2. Urinary Tract

12.4.3. Surgical Site

12.4.4. Gastrointestinal

12.4.5. Respiratory

12.4.6. Others

12.5. Market Value Forecast, by Sample Type, 2020-2034

12.5.1. Blood

12.5.2. Urine

12.5.3. Stool

12.5.4. Tissue

12.5.5. Others

12.6. Market Value Forecast, by End-user, 2020-2034

12.6.1. Hospitals & Clinics

12.6.2. Nursing Homes

12.6.3. Ambulatory Surgical Centers

12.6.4. Others

12.7. Market Value Forecast, by Country/Sub-region, 2020-2034

12.7.1. Germany

12.7.2. U.K.

12.7.3. France

12.7.4. Italy

12.7.5. Spain

12.7.6. Switzerland

12.7.7. Netherlands

12.7.8. Rest of Europe

12.8. Market Attractiveness Analysis

12.8.1. By Product

12.8.2. By Test Type

12.8.3. By Target Area

12.8.4. By Sample Type

12.8.5. By End-user

12.8.6. By Country/Sub-region

12.9. Germany Culture Test for Healthcare-associated Infections Market Analysis and Forecast

12.9.1. Introduction

12.9.1.1. Key Findings

12.9.2. Market Value Forecast, by Product, 2020-2034

12.9.2.1. Instruments

12.9.2.2. Reagents and Consumables

12.9.3. Market Value & Volume Forecast, by Test Type, 2020-2034

12.9.3.1. Escherichia coli infection

12.9.3.2. Staphylococcus aureus infection

12.9.3.3. Enterococcus species infection

12.9.3.4. Pseudomonas aeruginosa infection

12.9.3.5. Clostridioides difficile infection

12.9.3.6. Enterobacter Species

12.9.3.7. Others

12.9.4. Market Value Forecast, by Target Area, 2020-2034

12.9.4.1. Bloodstream

12.9.4.2. Urinary Tract

12.9.4.3. Surgical Site

12.9.4.4. Gastrointestinal

12.9.4.5. Respiratory

12.9.4.6. Others

12.9.5. Market Value Forecast, by Sample Type, 2020-2034

12.9.5.1. Blood

12.9.5.2. Urine

12.9.5.3. Stool

12.9.5.4. Tissue

12.9.5.5. Others

12.9.6. Market Value Forecast, by End-user, 2020-2034

12.9.6.1. Hospitals & Clinics

12.9.6.2. Nursing Homes

12.9.6.3. Ambulatory Surgical Centers

12.9.6.4. Others

12.9.7. Market Attractiveness Analysis

12.9.7.1. By Product

12.9.7.2. By Test Type

12.9.7.3. By Target Area

12.9.7.4. By Sample Type

12.9.7.5. By End-user

12.10. U.K Culture Test for Healthcare-associated Infections Market Analysis and Forecast

12.10.1. Introduction

12.10.1.1. Key Findings

12.10.2. Market Value Forecast, by Product, 2020-2034

12.10.2.1. Instruments

12.10.2.2. Reagents and Consumables

12.10.3. Market Value & Volume Forecast, by Test Type, 2020-2034

12.10.3.1. Escherichia coli infection

12.10.3.2. Staphylococcus aureus infection

12.10.3.3. Enterococcus species infection

12.10.3.4. Pseudomonas aeruginosa infection

12.10.3.5. Clostridioides difficile infection

12.10.3.6. Enterobacter Species

12.10.3.7. Others

12.10.4. Market Value Forecast, by Target Area, 2020-2034

12.10.4.1. Bloodstream

12.10.4.2. Urinary Tract

12.10.4.3. Surgical Site

12.10.4.4. Gastrointestinal

12.10.4.5. Respiratory

12.10.4.6. Others

12.10.5. Market Value Forecast, by Sample Type, 2020-2034

12.10.5.1. Blood

12.10.5.2. Urine

12.10.5.3. Stool

12.10.5.4. Tissue

12.10.5.5. Others

12.10.6. Market Value Forecast, by End-user, 2020-2034

12.10.6.1. Hospitals & Clinics

12.10.6.2. Nursing Homes

12.10.6.3. Ambulatory Surgical Centers

12.10.6.4. Others

12.10.7. Market Attractiveness Analysis

12.10.7.1. By Product

12.10.7.2. By Test Type

12.10.7.3. By Target Area

12.10.7.4. By Sample Type

12.10.7.5. By End-user

12.11. France Culture Test for Healthcare-associated Infections Market Analysis and Forecast

12.11.1. Introduction

12.11.1.1. Key Findings

12.11.2. Market Value Forecast, by Product, 2020-2034

12.11.2.1. Instruments

12.11.2.2. Reagents and Consumables

12.11.3. Market Value & Volume Forecast, by Test Type, 2020-2034

12.11.3.1. Escherichia coli infection

12.11.3.2. Staphylococcus aureus infection

12.11.3.3. Enterococcus species infection

12.11.3.4. Pseudomonas aeruginosa infection

12.11.3.5. Clostridioides difficile infection

12.11.3.6. Enterobacter Species

12.11.3.7. Others

12.11.4. Market Value Forecast, by Target Area, 2020-2034

12.11.4.1. Bloodstream

12.11.4.2. Urinary Tract

12.11.4.3. Surgical Site

12.11.4.4. Gastrointestinal

12.11.4.5. Respiratory

12.11.4.6. Others

12.11.5. Market Value Forecast, by Sample Type, 2020-2034

12.11.5.1. Blood

12.11.5.2. Urine

12.11.5.3. Stool

12.11.5.4. Tissue

12.11.5.5. Others

12.11.6. Market Value Forecast, by End-user, 2020-2034

12.11.6.1. Hospitals & Clinics

12.11.6.2. Nursing Homes

12.11.6.3. Ambulatory Surgical Centers

12.11.6.4. Others

12.11.7. Market Attractiveness Analysis

12.11.7.1. By Product

12.11.7.2. By Test Type

12.11.7.3. By Target Area

12.11.7.4. By Sample Type

12.11.7.5. By End-user

12.12. Italy Culture Test for Healthcare-associated Infections Market Analysis and Forecast

12.12.1. Introduction

12.12.1.1. Key Findings

12.12.2. Market Value Forecast, by Product, 2020-2034

12.12.2.1. Instruments

12.12.2.2. Reagents and Consumables

12.12.3. Market Value & Volume Forecast, by Test Type, 2020-2034

12.12.3.1. Escherichia coli infection

12.12.3.2. Staphylococcus aureus infection

12.12.3.3. Enterococcus species infection

12.12.3.4. Pseudomonas aeruginosa infection

12.12.3.5. Clostridioides difficile infection

12.12.3.6. Enterobacter Species

12.12.3.7. Others

12.12.4. Market Value Forecast, by Target Area, 2020-2034

12.12.4.1. Bloodstream

12.12.4.2. Urinary Tract

12.12.4.3. Surgical Site

12.12.4.4. Gastrointestinal

12.12.4.5. Respiratory

12.12.4.6. Others

12.12.5. Market Value Forecast, by Sample Type, 2020-2034

12.12.5.1. Blood

12.12.5.2. Urine

12.12.5.3. Stool

12.12.5.4. Tissue

12.12.5.5. Others

12.12.6. Market Value Forecast, by End-user, 2020-2034

12.12.6.1. Hospitals & Clinics

12.12.6.2. Nursing Homes

12.12.6.3. Ambulatory Surgical Centers

12.12.6.4. Others

12.12.7. Market Attractiveness Analysis

12.12.7.1. By Product

12.12.7.2. By Test Type

12.12.7.3. By Target Area

12.12.7.4. By Sample Type

12.12.7.5. By End-user

12.13. Spain Culture Test for Healthcare-associated Infections Market Analysis and Forecast

12.13.1. Introduction

12.13.1.1. Key Findings

12.13.2. Market Value Forecast, by Product, 2020-2034

12.13.2.1. Instruments

12.13.2.2. Reagents and Consumables

12.13.3. Market Value & Volume Forecast, by Test Type, 2020-2034

12.13.3.1. Escherichia coli infection

12.13.3.2. Staphylococcus aureus infection

12.13.3.3. Enterococcus species infection

12.13.3.4. Pseudomonas aeruginosa infection

12.13.3.5. Clostridioides difficile infection

12.13.3.6. Enterobacter Species

12.13.3.7. Others

12.13.4. Market Value Forecast, by Target Area, 2020-2034

12.13.4.1. Bloodstream

12.13.4.2. Urinary Tract

12.13.4.3. Surgical Site

12.13.4.4. Gastrointestinal

12.13.4.5. Respiratory

12.13.4.6. Others

12.13.5. Market Value Forecast, by Sample Type, 2020-2034

12.13.5.1. Blood

12.13.5.2. Urine

12.13.5.3. Stool

12.13.5.4. Tissue

12.13.5.5. Others

12.13.6. Market Value Forecast, by End-user, 2020-2034

12.13.6.1. Hospitals & Clinics

12.13.6.2. Nursing Homes

12.13.6.3. Ambulatory Surgical Centers

12.13.6.4. Others

12.13.7. Market Attractiveness Analysis

12.13.7.1. By Product

12.13.7.2. By Test Type

12.13.7.3. By Target Area

12.13.7.4. By Sample Type

12.13.7.5. By End-user

12.14. Switzerland Culture Test for Healthcare-associated Infections Market Analysis and Forecast

12.14.1. Introduction

12.14.1.1. Key Findings

12.14.2. Market Value Forecast, by Product, 2020-2034

12.14.2.1. Instruments

12.14.2.2. Reagents and Consumables

12.14.3. Market Value & Volume Forecast, by Test Type, 2020-2034

12.14.3.1. Escherichia coli infection

12.14.3.2. Staphylococcus aureus infection

12.14.3.3. Enterococcus species infection

12.14.3.4. Pseudomonas aeruginosa infection

12.14.3.5. Clostridioides difficile infection

12.14.3.6. Enterobacter Species

12.14.3.7. Others

12.14.4. Market Value Forecast, by Target Area, 2020-2034

12.14.4.1. Bloodstream

12.14.4.2. Urinary Tract

12.14.4.3. Surgical Site

12.14.4.4. Gastrointestinal

12.14.4.5. Respiratory

12.14.4.6. Others

12.14.5. Market Value Forecast, by Sample Type, 2020-2034

12.14.5.1. Blood

12.14.5.2. Urine

12.14.5.3. Stool

12.14.5.4. Tissue

12.14.5.5. Others

12.14.6. Market Value Forecast, by End-user, 2020-2034

12.14.6.1. Hospitals & Clinics

12.14.6.2. Nursing Homes

12.14.6.3. Ambulatory Surgical Centers

12.14.6.4. Others

12.14.7. Market Attractiveness Analysis

12.14.7.1. By Product

12.14.7.2. By Test Type

12.14.7.3. By Target Area

12.14.7.4. By Sample Type

12.14.7.5. By End-user

12.15. Netherlands Culture Test for Healthcare-associated Infections Market Analysis and Forecast

12.15.1. Introduction

12.15.1.1. Key Findings

12.15.2. Market Value Forecast, by Product, 2020-2034

12.15.2.1. Instruments

12.15.2.2. Reagents and Consumables

12.15.3. Market Value & Volume Forecast, by Test Type, 2020-2034

12.15.3.1. Escherichia coli infection

12.15.3.2. Staphylococcus aureus infection

12.15.3.3. Enterococcus species infection

12.15.3.4. Pseudomonas aeruginosa infection

12.15.3.5. Clostridioides difficile infection

12.15.3.6. Enterobacter Species

12.15.3.7. Others

12.15.4. Market Value Forecast, by Target Area, 2020-2034

12.15.4.1. Bloodstream

12.15.4.2. Urinary Tract

12.15.4.3. Surgical Site

12.15.4.4. Gastrointestinal

12.15.4.5. Respiratory

12.15.4.6. Others

12.15.5. Market Value Forecast, by Sample Type, 2020-2034

12.15.5.1. Blood

12.15.5.2. Urine

12.15.5.3. Stool

12.15.5.4. Tissue

12.15.5.5. Others

12.15.6. Market Value Forecast, by End-user, 2020-2034

12.15.6.1. Hospitals & Clinics

12.15.6.2. Nursing Homes

12.15.6.3. Ambulatory Surgical Centers

12.15.6.4. Others

12.15.7. Market Attractiveness Analysis

12.15.7.1. By Product

12.15.7.2. By Test Type

12.15.7.3. By Target Area

12.15.7.4. By Sample Type

12.15.7.5. By End-user

12.16. Rest of Europe Culture Test for Healthcare-associated Infections Market Analysis and Forecast

12.16.1. Introduction

12.16.1.1. Key Findings

12.16.2. Market Value Forecast, by Product, 2020-2034

12.16.2.1. Instruments

12.16.2.2. Reagents and Consumables

12.16.3. Market Value & Volume Forecast, by Test Type, 2020-2034

12.16.3.1. Escherichia coli infection

12.16.3.2. Staphylococcus aureus infection

12.16.3.3. Enterococcus species infection

12.16.3.4. Pseudomonas aeruginosa infection

12.16.3.5. Clostridioides difficile infection

12.16.3.6. Enterobacter Species

12.16.3.7. Others

12.16.4. Market Value Forecast, by Target Area, 2020-2034

12.16.4.1. Bloodstream

12.16.4.2. Urinary Tract

12.16.4.3. Surgical Site

12.16.4.4. Gastrointestinal

12.16.4.5. Respiratory

12.16.4.6. Others

12.16.5. Market Value Forecast, by Sample Type, 2020-2034

12.16.5.1. Blood

12.16.5.2. Urine

12.16.5.3. Stool

12.16.5.4. Tissue

12.16.5.5. Others

12.16.6. Market Value Forecast, by End-user, 2020-2034

12.16.6.1. Hospitals & Clinics

12.16.6.2. Nursing Homes

12.16.6.3. Ambulatory Surgical Centers

12.16.6.4. Others

12.16.7. Market Attractiveness Analysis

12.16.7.1. By Product

12.16.7.2. By Test Type

12.16.7.3. By Target Area

12.16.7.4. By Sample Type

12.16.7.5. By End-user

13. MEA Culture Test for Healthcare-associated Infections Market Analysis and Forecast

13.1. Introduction

13.1.1. Key Findings

13.2. Market Value Forecast, by Product, 2020-2034

13.2.1. Instruments

13.2.2. Reagents and Consumables

13.3. Market Value & Volume Forecast, by Test Type, 2020-2034

13.3.1. Escherichia coli infection

13.3.2. Staphylococcus aureus infection

13.3.3. Enterococcus species infection

13.3.4. Pseudomonas aeruginosa infection

13.3.5. Clostridioides difficile infection

13.3.6. Enterobacter Species

13.3.7. Others

13.4. Market Value Forecast, by Target Area, 2020-2034

13.4.1. Bloodstream

13.4.2. Urinary Tract

13.4.3. Surgical Site

13.4.4. Gastrointestinal

13.4.5. Respiratory

13.4.6. Others

13.5. Market Value Forecast, by Sample Type, 2020-2034

13.5.1. Blood

13.5.2. Urine

13.5.3. Stool

13.5.4. Tissue

13.5.5. Others

13.6. Market Value Forecast, by End-user, 2020-2034

13.6.1. Hospitals & Clinics

13.6.2. Nursing Homes

13.6.3. Ambulatory Surgical Centers

13.6.4. Others

13.7. Market Value Forecast, by Country/Sub-region, 2020-2034

13.7.1. Saudi Arabia

13.7.2. UAE

13.7.3. South Africa

13.7.4. Turkey

13.7.5. Egypt

13.7.6. Israel

13.7.7. Rest of MEA

13.8. Market Attractiveness Analysis

13.8.1. By Product

13.8.2. By Test Type

13.8.3. By Target Area

13.8.4. By Sample Type

13.8.5. By End-user

13.8.6. By Country/Sub-region

13.9. Saudi Arabia Culture Test for Healthcare-associated Infections Market Analysis and Forecast

13.9.1. Introduction

13.9.1.1. Key Findings

13.9.2. Market Value Forecast, by Product, 2020-2034

13.9.2.1. Instruments

13.9.2.2. Reagents and Consumables

13.9.3. Market Value & Volume Forecast, by Test Type, 2020-2034

13.9.3.1. Escherichia coli infection

13.9.3.2. Staphylococcus aureus infection

13.9.3.3. Enterococcus species infection

13.9.3.4. Pseudomonas aeruginosa infection

13.9.3.5. Clostridioides difficile infection

13.9.3.6. Enterobacter Species

13.9.3.7. Others

13.9.4. Market Value Forecast, by Target Area, 2020-2034

13.9.4.1. Bloodstream

13.9.4.2. Urinary Tract

13.9.4.3. Surgical Site

13.9.4.4. Gastrointestinal

13.9.4.5. Respiratory

13.9.4.6. Others

13.9.5. Market Value Forecast, by Sample Type, 2020-2034

13.9.5.1. Blood

13.9.5.2. Urine

13.9.5.3. Stool

13.9.5.4. Tissue

13.9.5.5. Others

13.9.6. Market Value Forecast, by End-user, 2020-2034

13.9.6.1. Hospitals & Clinics

13.9.6.2. Nursing Homes

13.9.6.3. Ambulatory Surgical Centers

13.9.6.4. Others

13.9.7. Market Attractiveness Analysis

13.9.7.1. By Product

13.9.7.2. By Test Type

13.9.7.3. By Target Area

13.9.7.4. By Sample Type

13.9.7.5. By End-user

13.10. UAE Culture Test for Healthcare-associated Infections Market Analysis and Forecast

13.10.1. Introduction

13.10.1.1. Key Findings

13.10.2. Market Value Forecast, by Product, 2020-2034

13.10.2.1. Instruments

13.10.2.2. Reagents and Consumables

13.10.3. Market Value & Volume Forecast, by Test Type, 2020-2034

13.10.3.1. Escherichia coli infection

13.10.3.2. Staphylococcus aureus infection

13.10.3.3. Enterococcus species infection

13.10.3.4. Pseudomonas aeruginosa infection

13.10.3.5. Clostridioides difficile infection

13.10.3.6. Enterobacter Species

13.10.3.7. Others

13.10.4. Market Value Forecast, by Target Area, 2020-2034

13.10.4.1. Bloodstream

13.10.4.2. Urinary Tract

13.10.4.3. Surgical Site

13.10.4.4. Gastrointestinal

13.10.4.5. Respiratory

13.10.4.6. Others

13.10.5. Market Value Forecast, by Sample Type, 2020-2034

13.10.5.1. Blood

13.10.5.2. Urine

13.10.5.3. Stool

13.10.5.4. Tissue

13.10.5.5. Others

13.10.6. Market Value Forecast, by End-user, 2020-2034

13.10.6.1. Hospitals & Clinics

13.10.6.2. Nursing Homes

13.10.6.3. Ambulatory Surgical Centers

13.10.6.4. Others

13.10.7. Market Attractiveness Analysis

13.10.7.1. By Product

13.10.7.2. By Test Type

13.10.7.3. By Target Area

13.10.7.4. By Sample Type

13.10.7.5. By End-user

13.11. South Africa Culture Test for Healthcare-associated Infections Market Analysis and Forecast

13.11.1. Introduction

13.11.1.1. Key Findings

13.11.2. Market Value Forecast, by Product, 2020-2034

13.11.2.1. Instruments

13.11.2.2. Reagents and Consumables

13.11.3. Market Value & Volume Forecast, by Test Type, 2020-2034

13.11.3.1. Escherichia coli infection

13.11.3.2. Staphylococcus aureus infection

13.11.3.3. Enterococcus species infection

13.11.3.4. Pseudomonas aeruginosa infection

13.11.3.5. Clostridioides difficile infection

13.11.3.6. Enterobacter Species

13.11.3.7. Others

13.11.4. Market Value Forecast, by Target Area, 2020-2034

13.11.4.1. Bloodstream

13.11.4.2. Urinary Tract

13.11.4.3. Surgical Site

13.11.4.4. Gastrointestinal

13.11.4.5. Respiratory

13.11.4.6. Others

13.11.5. Market Value Forecast, by Sample Type, 2020-2034

13.11.5.1. Blood

13.11.5.2. Urine

13.11.5.3. Stool

13.11.5.4. Tissue

13.11.5.5. Others

13.11.6. Market Value Forecast, by End-user, 2020-2034

13.11.6.1. Hospitals & Clinics

13.11.6.2. Nursing Homes

13.11.6.3. Ambulatory Surgical Centers

13.11.6.4. Others

13.11.7. Market Attractiveness Analysis

13.11.7.1. By Product

13.11.7.2. By Test Type

13.11.7.3. By Target Area

13.11.7.4. By Sample Type

13.11.7.5. By End-user

13.12. Turkey Culture Test for Healthcare-associated Infections Market Analysis and Forecast

13.12.1. Introduction

13.12.1.1. Key Findings

13.12.2. Market Value Forecast, by Product, 2020-2034

13.12.2.1. Instruments

13.12.2.2. Reagents and Consumables

13.12.3. Market Value & Volume Forecast, by Test Type, 2020-2034

13.12.3.1. Escherichia coli infection

13.12.3.2. Staphylococcus aureus infection

13.12.3.3. Enterococcus species infection

13.12.3.4. Pseudomonas aeruginosa infection

13.12.3.5. Clostridioides difficile infection

13.12.3.6. Enterobacter Species

13.12.3.7. Others

13.12.4. Market Value Forecast, by Target Area, 2020-2034

13.12.4.1. Bloodstream

13.12.4.2. Urinary Tract

13.12.4.3. Surgical Site

13.12.4.4. Gastrointestinal

13.12.4.5. Respiratory

13.12.4.6. Others

13.12.5. Market Value Forecast, by Sample Type, 2020-2034

13.12.5.1. Blood

13.12.5.2. Urine

13.12.5.3. Stool

13.12.5.4. Tissue

13.12.5.5. Others

13.12.6. Market Value Forecast, by End-user, 2020-2034

13.12.6.1. Hospitals & Clinics

13.12.6.2. Nursing Homes

13.12.6.3. Ambulatory Surgical Centers

13.12.6.4. Others

13.12.7. Market Attractiveness Analysis

13.12.7.1. By Product

13.12.7.2. By Test Type

13.12.7.3. By Target Area

13.12.7.4. By Sample Type

13.12.7.5. By End-user

13.13. Egypt Culture Test for Healthcare-associated Infections Market Analysis and Forecast

13.13.1. Introduction

13.13.1.1. Key Findings

13.13.2. Market Value Forecast, by Product, 2020-2034

13.13.2.1. Instruments

13.13.2.2. Reagents and Consumables

13.13.3. Market Value & Volume Forecast, by Test Type, 2020-2034

13.13.3.1. Escherichia coli infection

13.13.3.2. Staphylococcus aureus infection

13.13.3.3. Enterococcus species infection

13.13.3.4. Pseudomonas aeruginosa infection

13.13.3.5. Clostridioides difficile infection

13.13.3.6. Enterobacter Species

13.13.3.7. Others

13.13.4. Market Value Forecast, by Target Area, 2020-2034

13.13.4.1. Bloodstream

13.13.4.2. Urinary Tract

13.13.4.3. Surgical Site

13.13.4.4. Gastrointestinal

13.13.4.5. Respiratory

13.13.4.6. Others

13.13.5. Market Value Forecast, by Sample Type, 2020-2034

13.13.5.1. Blood

13.13.5.2. Urine

13.13.5.3. Stool

13.13.5.4. Tissue

13.13.5.5. Others

13.13.6. Market Value Forecast, by End-user, 2020-2034

13.13.6.1. Hospitals & Clinics

13.13.6.2. Nursing Homes

13.13.6.3. Ambulatory Surgical Centers

13.13.6.4. Others

13.13.7. Market Attractiveness Analysis

13.13.7.1. By Product

13.13.7.2. By Test Type

13.13.7.3. By Target Area

13.13.7.4. By Sample Type

13.13.7.5. By End-user

13.14. Israel Culture Test for Healthcare-associated Infections Market Analysis and Forecast

13.14.1. Introduction

13.14.1.1. Key Findings

13.14.2. Market Value Forecast, by Product, 2020-2034

13.14.2.1. Instruments

13.14.2.2. Reagents and Consumables

13.14.3. Market Value & Volume Forecast, by Test Type, 2020-2034

13.14.3.1. Escherichia coli infection

13.14.3.2. Staphylococcus aureus infection

13.14.3.3. Enterococcus species infection

13.14.3.4. Pseudomonas aeruginosa infection

13.14.3.5. Clostridioides difficile infection

13.14.3.6. Enterobacter Species

13.14.3.7. Others

13.14.4. Market Value Forecast, by Target Area, 2020-2034

13.14.4.1. Bloodstream

13.14.4.2. Urinary Tract

13.14.4.3. Surgical Site

13.14.4.4. Gastrointestinal

13.14.4.5. Respiratory

13.14.4.6. Others

13.14.5. Market Value Forecast, by Sample Type, 2020-2034

13.14.5.1. Blood

13.14.5.2. Urine

13.14.5.3. Stool

13.14.5.4. Tissue

13.14.5.5. Others

13.14.6. Market Value Forecast, by End-user, 2020-2034

13.14.6.1. Hospitals & Clinics

13.14.6.2. Nursing Homes

13.14.6.3. Ambulatory Surgical Centers

13.14.6.4. Others

13.14.7. Market Attractiveness Analysis

13.14.7.1. By Product

13.14.7.2. By Test Type

13.14.7.3. By Target Area

13.14.7.4. By Sample Type

13.14.7.5. By End-user

13.15. Rest of MEA Culture Test for Healthcare-associated Infections Market Analysis and Forecast

13.15.1. Introduction

13.15.1.1. Key Findings

13.15.2. Market Value Forecast, by Product, 2020-2034

13.15.2.1. Instruments

13.15.2.2. Reagents and Consumables

13.15.3. Market Value & Volume Forecast, by Test Type, 2020-2034

13.15.3.1. Escherichia coli infection

13.15.3.2. Staphylococcus aureus infection

13.15.3.3. Enterococcus species infection

13.15.3.4. Pseudomonas aeruginosa infection

13.15.3.5. Clostridioides difficile infection

13.15.3.6. Enterobacter Species

13.15.3.7. Others

13.15.4. Market Value Forecast, by Target Area, 2020-2034

13.15.4.1. Bloodstream

13.15.4.2. Urinary Tract

13.15.4.3. Surgical Site

13.15.4.4. Gastrointestinal

13.15.4.5. Respiratory

13.15.4.6. Others

13.15.5. Market Value Forecast, by Sample Type, 2020-2034

13.15.5.1. Blood

13.15.5.2. Urine

13.15.5.3. Stool

13.15.5.4. Tissue

13.15.5.5. Others

13.15.6. Market Value Forecast, by End-user, 2020-2034

13.15.6.1. Hospitals & Clinics

13.15.6.2. Nursing Homes

13.15.6.3. Ambulatory Surgical Centers

13.15.6.4. Others

13.15.7. Market Attractiveness Analysis

13.15.7.1. By Product

13.15.7.2. By Test Type

13.15.7.3. By Target Area

13.15.7.4. By Sample Type

13.15.7.5. By End-user

14. Competition Landscape

14.1. Market Player - Competition Matrix (By Tier and Size of Companies)

14.2. Market Share Analysis, by Company (2023)

14.3. Company Profiles

14.3.1. Abbott Laboratories

14.3.1.1. Company Overview

14.3.1.2. Financial Overview

14.3.1.3. Product Portfolio

14.3.1.4. Business Strategies

14.3.1.5. Recent Developments

14.3.2. Merck KGA

14.3.2.1. Company Overview

14.3.2.2. Financial Overview

14.3.2.3. Product Portfolio

14.3.2.4. Business Strategies

14.3.2.5. Recent Developments

14.3.3. Becton Dickinson and Company

14.3.3.1. Company Overview

14.3.3.2. Financial Overview

14.3.3.3. Product Portfolio

14.3.3.4. Business Strategies

14.3.3.5. Recent Developments

14.3.4. Steris Plc

14.3.4.1. Company Overview

14.3.4.2. Financial Overview

14.3.4.3. Product Portfolio

14.3.4.4. Business Strategies

14.3.4.5. Recent Developments

14.3.5. Hologic, Inc.

14.3.5.1. Company Overview

14.3.5.2. Financial Overview

14.3.5.3. Product Portfolio

14.3.5.4. Business Strategies

14.3.5.5. Recent Developments

14.3.6. bioMerieux SA

14.3.6.1. Company Overview

14.3.6.2. Financial Overview

14.3.6.3. Product Portfolio

14.3.6.4. Business Strategies

14.3.6.5. Recent Developments

14.3.7. F. Hoffmann-La Roche AG

14.3.7.1. Company Overview

14.3.7.2. Financial Overview

14.3.7.3. Product Portfolio

14.3.7.4. Business Strategies

14.3.7.5. Recent Developments

14.3.8. Siemens Healthineers AG

14.3.8.1. Company Overview

14.3.8.2. Financial Overview

14.3.8.3. Product Portfolio

14.3.8.4. Business Strategies

14.3.8.5. Recent Developments

14.3.9. Thermo Fisher Scientific Inc.

14.3.9.1. Company Overview

14.3.9.2. Financial Overview

14.3.9.3. Product Portfolio

14.3.9.4. Business Strategies

14.3.9.5. Recent Developments

14.3.10. Hardy Diagnostics

14.3.10.1. Company Overview

14.3.10.2. Financial Overview

14.3.10.3. Product Portfolio

14.3.10.4. Business Strategies

14.3.10.5. Recent Developments

14.3.11. Bio-Rad Laboratories, Inc.

14.3.11.1. Company Overview

14.3.11.2. Financial Overview

14.3.11.3. Product Portfolio

14.3.11.4. Business Strategies

14.3.11.5. Recent Developments

14.3.12. Danaher Corporation

14.3.12.1. Company Overview

14.3.12.2. Financial Overview

14.3.12.3. Product Portfolio

14.3.12.4. Business Strategies

14.3.12.5. Recent Developments

14.3.13. SSI Diagnostica A/S

14.3.13.1. Company Overview

14.3.13.2. Financial Overview

14.3.13.3. Product Portfolio

14.3.13.4. Business Strategies

14.3.13.5. Recent Developments

List of Tables

Table 01: Europe and MEA Culture Test for Healthcare-associated Infections Market Value (US$ Mn) Forecast, by Product, 2020-2034

Table 02: Europe and MEA Culture Test for Healthcare-associated Infections Market Value (US$ Mn) Forecast, by Test Type, 2020-2034

Table 03: Europe and MEA Culture Test for Healthcare-associated Infections Market Volume (Thousand Units) Forecast, by Test Type, 2020-2034

Table 04: Europe and MEA Culture Test for Healthcare-associated Infections Market Value (US$ Mn) Forecast, by Target Area, 2020-2034

Table 05: Europe and MEA Culture Test for Healthcare-associated Infections Market Value (US$ Mn) Forecast, by Sample Type, 2020-2034

Table 06: Europe and MEA Culture Test for Healthcare-associated Infections Market Value (US$ Mn) Forecast, by End-user, 2020-2034

Table 07: Europe and MEA Culture Test for Healthcare-associated Infections Market Value (US$ Mn) Forecast, by Region, 2020-2034

Table 08: Europe Culture Test for Healthcare-associated Infections Market Value (US$ Mn) Forecast, by Country / Sub-region, 2020-2034

Table 09: Europe Culture Test for Healthcare-associated Infections Market Value (US$ Mn) Forecast, by Product, 2020-2034

Table 10: Europe Culture Test for Healthcare-associated Infections Market Value (US$ Mn) Forecast, by Test Type, 2020-2034

Table 11: Europe Culture Test for Healthcare-associated Infections Market Volume (Thousand Units) Forecast, by Test Type, 2020-2034

Table 12: Europe Culture Test for Healthcare-associated Infections Market Value (US$ Mn) Forecast, by Target Area, 2020-2034

Table 13: Europe Culture Test for Healthcare-associated Infections Market Value (US$ Mn) Forecast, by Sample Type, 2020-2034

Table 14: Europe Culture Test for Healthcare-associated Infections Market Value (US$ Mn) Forecast, by End-user, 2020-2034

Table 15: Germany Culture Test for Healthcare-associated Infections Market Value (US$ Mn) Forecast, by Product, 2020-2034

Table 16: Germany Culture Test for Healthcare-associated Infections Market Value (US$ Mn) Forecast, by Test Type, 2020-2034

Table 17: Germany Culture Test for Healthcare-associated Infections Market Volume (Thousand Units) Forecast, by Test Type, 2020-2034

Table 18: Germany Culture Test for Healthcare-associated Infections Market Value (US$ Mn) Forecast, by Target Area, 2020-2034

Table 19: Germany Culture Test for Healthcare-associated Infections Market Value (US$ Mn) Forecast, by Sample Type, 2020-2034

Table 20: Germany Culture Test for Healthcare-associated Infections Market Value (US$ Mn) Forecast, by End-user, 2020-2034

Table 21: U.K. Culture Test for Healthcare-associated Infections Market Value (US$ Mn) Forecast, by Product, 2020-2034

Table 22: U.K. Culture Test for Healthcare-associated Infections Market Value (US$ Mn) Forecast, by Test Type, 2020-2034

Table 23: U.K. Culture Test for Healthcare-associated Infections Market Volume (Thousand Units) Forecast, by Test Type, 2020-2034

Table 24: U.K. Culture Test for Healthcare-associated Infections Market Value (US$ Mn) Forecast, by Target Area, 2020-2034

Table 25: U.K. Culture Test for Healthcare-associated Infections Market Value (US$ Mn) Forecast, by Sample Type, 2020-2034

Table 26: U.K. Culture Test for Healthcare-associated Infections Market Value (US$ Mn) Forecast, by End-user, 2020-2034

Table 27: France Culture Test for Healthcare-associated Infections Market Value (US$ Mn) Forecast, by Product, 2020-2034

Table 28: France Culture Test for Healthcare-associated Infections Market Value (US$ Mn) Forecast, by Test Type, 2020-2034

Table 29: France Culture Test for Healthcare-associated Infections Market Volume (Thousand Units) Forecast, by Test Type, 2020-2034

Table 30: France Culture Test for Healthcare-associated Infections Market Value (US$ Mn) Forecast, by Target Area, 2020-2034

Table 31: France Culture Test for Healthcare-associated Infections Market Value (US$ Mn) Forecast, by Sample Type, 2020-2034

Table 32: France Culture Test for Healthcare-associated Infections Market Value (US$ Mn) Forecast, by End-user, 2020-2034

Table 33: Italy Culture Test for Healthcare-associated Infections Market Value (US$ Mn) Forecast, by Product, 2020-2034

Table 34: Italy Culture Test for Healthcare-associated Infections Market Value (US$ Mn) Forecast, by Test Type, 2020-2034

Table 35: Italy Culture Test for Healthcare-associated Infections Market Volume (Thousand Units) Forecast, by Test Type, 2020-2034

Table 36: Italy Culture Test for Healthcare-associated Infections Market Value (US$ Mn) Forecast, by Target Area, 2020-2034

Table 37: Italy Culture Test for Healthcare-associated Infections Market Value (US$ Mn) Forecast, by Sample Type, 2020-2034

Table 38: Italy Culture Test for Healthcare-associated Infections Market Value (US$ Mn) Forecast, by End-user, 2020-2034

Table 39: Spain Culture Test for Healthcare-associated Infections Market Value (US$ Mn) Forecast, by Product, 2020-2034

Table 40: Spain Culture Test for Healthcare-associated Infections Market Value (US$ Mn) Forecast, by Test Type, 2020-2034

Table 41: Spain Culture Test for Healthcare-associated Infections Market Volume (Thousand Units) Forecast, by Test Type, 2020-2034

Table 42: Spain Culture Test for Healthcare-associated Infections Market Value (US$ Mn) Forecast, by Target Area, 2020-2034

Table 43: Spain Culture Test for Healthcare-associated Infections Market Value (US$ Mn) Forecast, by Sample Type, 2020-2034

Table 44: Spain Culture Test for Healthcare-associated Infections Market Value (US$ Mn) Forecast, by End-user, 2020-2034

Table 45: Switzerland Culture Test for Healthcare-associated Infections Market Value (US$ Mn) Forecast, by Product, 2020-2034

Table 46: Switzerland Culture Test for Healthcare-associated Infections Market Value (US$ Mn) Forecast, by Test Type, 2020-2034

Table 47: Switzerland Culture Test for Healthcare-associated Infections Market Volume Forecast, by Test Type, 2020-2034

Table 48: Switzerland Culture Test for Healthcare-associated Infections Market Value (US$ Mn) Forecast, by Target Area, 2020-2034

Table 49: Switzerland Culture Test for Healthcare-associated Infections Market Value (US$ Mn) Forecast, by Sample Type, 2020-2034

Table 50: Switzerland Culture Test for Healthcare-associated Infections Market Value (US$ Mn) Forecast, by End-user, 2020-2034

Table 51: Netherlands Culture Test for Healthcare-associated Infections Market Value (US$ Mn) Forecast, by Product, 2020-2034

Table 52: Netherlands Culture Test for Healthcare-associated Infections Market Value (US$ Mn) Forecast, by Test Type, 2020-2034

Table 53: Netherlands Culture Test for Healthcare-associated Infections Market Volume Forecast, by Test Type, 2020-2034

Table 54: Netherlands Culture Test for Healthcare-associated Infections Market Value (US$ Mn) Forecast, by Target Area, 2020-2034

Table 55: Netherlands Culture Test for Healthcare-associated Infections Market Value (US$ Mn) Forecast, by Sample Type, 2020-2034

Table 56: Netherlands Culture Test for Healthcare-associated Infections Market Value (US$ Mn) Forecast, by End-user, 2020-2034

Table 57: Rest of Europe Culture Test for Healthcare-associated Infections Market Value (US$ Mn) Forecast, by Product, 2020-2034

Table 58: Rest of Europe Culture Test for Healthcare-associated Infections Market Value (US$ Mn) Forecast, by Test Type, 2020-2034

Table 59: Rest of Europe Culture Test for Healthcare-associated Infections Market Volume Forecast, by Test Type, 2020-2034

Table 60: Rest of Europe Culture Test for Healthcare-associated Infections Market Value (US$ Mn) Forecast, by Target Area, 2020-2034

Table 61: Rest of Europe Culture Test for Healthcare-associated Infections Market Value (US$ Mn) Forecast, by Sample Type, 2020-2034

Table 62: Rest of Europe Culture Test for Healthcare-associated Infections Market Value (US$ Mn) Forecast, by End-user, 2020-2034

Table 63: Middle East and Africa Culture Test for Healthcare-associated Infections Market Value (US$ Mn) Forecast, by Test Type, 2020-2034

Table 64: Middle East and Africa Culture Test for Healthcare-associated Infections Market Value (US$ Mn) Forecast, by Product, 2020-2034

Table 65: Middle East and Africa Culture Test for Healthcare-associated Infections Market Value (US$ Mn) Forecast, by Test Type, 2020-2034

Table 66: Middle East and Africa Culture Test for Healthcare-associated Infections Market Volume (Thousand Units) Forecast, by Test Type, 2020-2034

Table 67: Middle East and Africa Culture Test for Healthcare-associated Infections Market Value (US$ Mn) Forecast, by Target Area, 2020-2034

Table 68: Middle East and Africa Culture Test for Healthcare-associated Infections Market Value (US$ Mn) Forecast, by Sample Type, 2020-2034

Table 69: Middle East and Africa Culture Test for Healthcare-associated Infections Market Value (US$ Mn) Forecast, by End-user, 2020-2034

Table 70: Saudi Arabia Culture Test for Healthcare-associated Infections Market Value (US$ Mn) Forecast, by Product, 2020-2034

Table 71: Saudi Arabia Culture Test for Healthcare-associated Infections Market Value (US$ Mn) Forecast, by Test Type, 2020-2034

Table 72: Saudi Arabia Culture Test for Healthcare-associated Infections Market Volume (Thousand Units) Forecast, by Test Type, 2020-2034

Table 73: Saudi Arabia Culture Test for Healthcare-associated Infections Market Value (US$ Mn) Forecast, by Target Area, 2020-2034

Table 74: Saudi Arabia Culture Test for Healthcare-associated Infections Market Value (US$ Mn) Forecast, by Sample Type, 2020-2034

Table 75: Saudi Arabia Culture Test for Healthcare-associated Infections Market Value (US$ Mn) Forecast, by End-user, 2020-2034

Table 76: UAE Culture Test for Healthcare-associated Infections Market Value (US$ Mn) Forecast, by Product, 2020-2034

Table 77: UAE Culture Test for Healthcare-associated Infections Market Value (US$ Mn) Forecast, by Test Type, 2020-2034

Table 78: UAE Culture Test for Healthcare-associated Infections Market Volume (Thousand Units) Forecast, by Test Type, 2020-2034

Table 79: UAE Culture Test for Healthcare-associated Infections Market Value (US$ Mn) Forecast, by Target Area, 2020-2034

Table 80: UAE Culture Test for Healthcare-associated Infections Market Value (US$ Mn) Forecast, by Sample Type, 2020-2034

Table 81: UAE Culture Test for Healthcare-associated Infections Market Value (US$ Mn) Forecast, by End-user, 2020-2034

Table 82: South Africa Culture Test for Healthcare-associated Infections Market Value (US$ Mn) Forecast, by Product, 2020-2034

Table 83: South Africa Culture Test for Healthcare-associated Infections Market Value (US$ Mn) Forecast, by Test Type, 2020-2034

Table 84: South Africa Culture Test for Healthcare-associated Infections Market Volume (Thousand Units) Forecast, by Test Type, 2020-2034

Table 85: South Africa Culture Test for Healthcare-associated Infections Market Value (US$ Mn) Forecast, by Target Area, 2020-2034

Table 86: South Africa Culture Test for Healthcare-associated Infections Market Value (US$ Mn) Forecast, by Sample Type, 2020-2034

Table 87: South Africa Culture Test for Healthcare-associated Infections Market Value (US$ Mn) Forecast, by End-user, 2020-2034

Table 88: Turkey Culture Test for Healthcare-associated Infections Market Value (US$ Mn) Forecast, by Product, 2020-2034

Table 89: Turkey Culture Test for Healthcare-associated Infections Market Value (US$ Mn) Forecast, by Test Type, 2020-2034

Table 90: Turkey Culture Test for Healthcare-associated Infections Market Volume (Thousand Units) Forecast, by Test Type, 2020-2034

Table 91: Turkey Culture Test for Healthcare-associated Infections Market Value (US$ Mn) Forecast, by Target Area, 2020-2034

Table 92: Turkey Culture Test for Healthcare-associated Infections Market Value (US$ Mn) Forecast, by Sample Type, 2020-2034

Table 93: Turkey Culture Test for Healthcare-associated Infections Market Value (US$ Mn) Forecast, by End-user, 2020-2034

Table 94: Egypt Culture Test for Healthcare-associated Infections Market Value (US$ Mn) Forecast, by Product, 2020-2034

Table 95: Egypt Culture Test for Healthcare-associated Infections Market Value (US$ Mn) Forecast, by Test Type, 2020-2034

Table 96: Egypt Culture Test for Healthcare-associated Infections Market Volume (Thousand Units) Forecast, by Test Type, 2020-2034

Table 97: Egypt Culture Test for Healthcare-associated Infections Market Value (US$ Mn) Forecast, by Target Area, 2020-2034

Table 98: Egypt Culture Test for Healthcare-associated Infections Market Value (US$ Mn) Forecast, by Sample Type, 2020-2034

Table 99: Egypt Culture Test for Healthcare-associated Infections Market Value (US$ Mn) Forecast, by End-user, 2020-2034

Table 100: Israel Culture Test for Healthcare-associated Infections Market Value (US$ Mn) Forecast, by Product, 2020-2034

Table 101: Israel Culture Test for Healthcare-associated Infections Market Value (US$ Mn) Forecast, by Test Type, 2020-2034

Table 102: Israel Culture Test for Healthcare-associated Infections Market Volume (Thousand Units) Forecast, by Test Type, 2020-2034

Table 103: Israel Culture Test for Healthcare-associated Infections Market Value (US$ Mn) Forecast, by Target Area, 2020-2034

Table 104: Israel Culture Test for Healthcare-associated Infections Market Value (US$ Mn) Forecast, by Sample Type, 2020-2034

Table 105: Israel Culture Test for Healthcare-associated Infections Market Value (US$ Mn) Forecast, by End-user, 2020-2034

Table 106: Rest of MEA Culture Test for Healthcare-associated Infections Market Value (US$ Mn) Forecast, by Product, 2020-2034

Table 107: Rest of MEA Culture Test for Healthcare-associated Infections Market Value (US$ Mn) Forecast, by Test Type, 2020-2034

Table 108: Rest of MEA Culture Test for Healthcare-associated Infections Market Volume Forecast, by Test Type, 2020-2034

Table 109: Rest of MEA Culture Test for Healthcare-associated Infections Market Value (US$ Mn) Forecast, by Target Area, 2020-2034

Table 110: Rest of MEA Culture Test for Healthcare-associated Infections Market Value (US$ Mn) Forecast, by Sample Type, 2020-2034

Table 111: Rest of MEA Culture Test for Healthcare-associated Infections Market Value (US$ Mn) Forecast, by End-user, 2020-2034

List of Figures

Figure 01: Europe and MEA Culture Test for Healthcare-associated Infections Market Value (US$ Mn) Forecast, 2020-2034

Figure 02: Europe and MEA Culture Test for Healthcare-associated Infections Market Value Share, by Product, 2023

Figure 03: Europe and MEA Culture Test for Healthcare-associated Infections Market Value Share, by Test Type, 2023

Figure 04: Europe and MEA Culture Test for Healthcare-associated Infections Market Value Share, by Target Area, 2023

Figure 05: Europe and MEA Culture Test for Healthcare-associated Infections Market Value Share, by Sample Type, 2023

Figure 06: Europe and MEA Culture Test for Healthcare-associated Infections Market Value Share, by End-user, 2023

Figure 07: Europe and MEA Culture Test for Healthcare-associated Infections Market Value (US$ Mn) Share Analysis, by Product, 2023 and 2034

Figure 08: Europe and MEA Culture Test for Healthcare-associated Infections Market Share Analysis, by Product, 2023

Figure 09: Europe and MEA Culture Test for Healthcare-associated Infections Market Share Analysis, by Product, 2034

Figure 10: Europe and MEA Culture Test for Healthcare-associated Infections Market Attractiveness Analysis, by Product, 2024-2034

Figure 11: Europe and MEA Culture Test for Healthcare-associated Infections Market Value (US$ Mn), by Instruments, 2020-2034

Figure 12: Europe and MEA Culture Test for Healthcare-associated Infections Market Value Share Analysis, by Instruments, 2023 and 2034

Figure 13: Europe and MEA Culture Test for Healthcare-associated Infections Market Value (US$ Mn), by Reagents and Consumables, 2020-2034

Figure 14: Europe and MEA Culture Test for Healthcare-associated Infections Market Value Share Analysis, by Reagents and Consumables, 2023 and 2034

Figure 15: Europe and MEA Culture Test for Healthcare-associated Infections Market Value (US$ Mn) Share Analysis, by Test Type, 2023 and 2034

Figure 16: Europe and MEA Culture Test for Healthcare-associated Infections Market Share Analysis, by Test Type, 2023

Figure 17: Europe and MEA Culture Test for Healthcare-associated Infections Market Share Analysis, by Test Type, 2034

Figure 18: Europe and MEA Culture Test for Healthcare-associated Infections Market Attractiveness Analysis, by Test Type, 2024-2034

Figure 19: Europe and MEA Culture Test for Healthcare-associated Infections Market Value (US$ Mn), by Escherichia coli infection, 2020-2034

Figure 20: Europe and MEA Culture Test for Healthcare-associated Infections Market Value Share Analysis, by Escherichia coli infection, 2023 and 2034

Figure 21: Europe and MEA Culture Test for Healthcare-associated Infections Market Value (US$ Mn), by Staphylococcus aureus infection, 2020-2034

Figure 22: Europe and MEA Culture Test for Healthcare-associated Infections Market Value Share Analysis, by Staphylococcus aureus infection, 2023 and 2034

Figure 23: Europe and MEA Culture Test for Healthcare-associated Infections Market Value (US$ Mn), by Enterococcus species infection, 2020-2034

Figure 24: Europe and MEA Culture Test for Healthcare-associated Infections Market Value Share Analysis, by Enterococcus species infection, 2023 and 2034

Figure 25: Europe and MEA Culture Test for Healthcare-associated Infections Market Value (US$ Mn), by Pseudomonas aeruginosa infection, 2020-2034

Figure 26: Europe and MEA Culture Test for Healthcare-associated Infections Market Value Share Analysis, by Pseudomonas aeruginosa infection, 2023 and 2034

Figure 27: Europe and MEA Culture Test for Healthcare-associated Infections Market Value (US$ Mn), by Clostridioides diffcile infection, 2020-2034

Figure 28: Europe and MEA Culture Test for Healthcare-associated Infections Market Value Share Analysis, by Clostridioides diffcile infection, 2023 and 2034

Figure 29: Europe and MEA Culture Test for Healthcare-associated Infections Market Value (US$ Mn), by Enterobacter Species, 2020-2034

Figure 30: Europe and MEA Culture Test for Healthcare-associated Infections Market Value Share Analysis, by Enterobacter Species, 2023 and 2034

Figure 31: Europe and MEA Culture Test for Healthcare-associated Infections Market Value (US$ Mn), by Others, 2020-2034

Figure 32: Europe and MEA Culture Test for Healthcare-associated Infections Market Value Share Analysis, by Others, 2023 and 2034

Figure 33: Europe and MEA Culture Test for Healthcare-associated Infections Market Value (US$ Mn) Share Analysis, by Target Area, 2023 and 2034

Figure 34: Europe and MEA Culture Test for Healthcare-associated Infections Market Share Analysis, by Target Area, 2023

Figure 35: Europe and MEA Culture Test for Healthcare-associated Infections Market Share Analysis, by Test Type, 2034

Figure 36: Europe and MEA Culture Test for Healthcare-associated Infections Market Attractiveness Analysis, by Target Area, 2024-2034

Figure 37: Europe and MEA Culture Test for Healthcare-associated Infections Market Value (US$ Mn), by Bloodstream, 2020-2034

Figure 38: Europe and MEA Culture Test for Healthcare-associated Infections Market Value Share Analysis, by Bloodstream, 2023 and 2034

Figure 39: Europe and MEA Culture Test for Healthcare-associated Infections Market Value (US$ Mn), by Urinary Tract, 2020-2034

Figure 40: Europe and MEA Culture Test for Healthcare-associated Infections Market Value Share Analysis, by Urinary Tract, 2023 and 2034

Figure 41: Europe and MEA Culture Test for Healthcare-associated Infections Market Value (US$ Mn), by Surgical Site, 2020-2034

Figure 42: Europe and MEA Culture Test for Healthcare-associated Infections Market Value Share Analysis, by Surgical Site, 2023 and 2034

Figure 43: Europe and MEA Culture Test for Healthcare-associated Infections Market Value (US$ Mn), by Gastrointestinal, 2020-2034

Figure 44: Europe and MEA Culture Test for Healthcare-associated Infections Market Value Share Analysis, by Gastrointestinal, 2023 and 2034

Figure 45: Europe and MEA Culture Test for Healthcare-associated Infections Market Value (US$ Mn), by Respiratory, 2020-2034

Figure 46: Europe and MEA Culture Test for Healthcare-associated Infections Market Value Share Analysis, by Respiratory, 2023 and 2034

Figure 47: Europe and MEA Culture Test for Healthcare-associated Infections Market Value (US$ Mn), by Others, 2020-2034

Figure 48: Europe and MEA Culture Test for Healthcare-associated Infections Market Value Share Analysis, by Others, 2023 and 2034

Figure 49: Europe and MEA Culture Test for Healthcare-associated Infections Market Value (US$ Mn) Share Analysis, by Sample Type, 2023 and 2034

Figure 50: Europe and MEA Culture Test for Healthcare-associated Infections Market Share Analysis, by Sample Type, 2023

Figure 51: Europe and MEA Culture Test for Healthcare-associated Infections Market Share Analysis, by Test Type, 2034

Figure 52: Europe and MEA Culture Test for Healthcare-associated Infections Market Attractiveness Analysis, by Sample Type, 2024-2034

Figure 53: Europe and MEA Culture Test for Healthcare-associated Infections Market Value (US$ Mn), by Blood, 2020-2034

Figure 54: Europe and MEA Culture Test for Healthcare-associated Infections Market Value Share Analysis, by Blood, 2023 and 2034

Figure 55: Europe and MEA Culture Test for Healthcare-associated Infections Market Value (US$ Mn), by Urine, 2020-2034

Figure 56: Europe and MEA Culture Test for Healthcare-associated Infections Market Value Share Analysis, by Urine, 2023 and 2034

Figure 57: Europe and MEA Culture Test for Healthcare-associated Infections Market Value (US$ Mn), by Stool, 2020-2034

Figure 58: Europe and MEA Culture Test for Healthcare-associated Infections Market Value Share Analysis, by Stool, 2023 and 2034

Figure 59: Europe and MEA Culture Test for Healthcare-associated Infections Market Value (US$ Mn), by Tissue, 2020-2034

Figure 60: Europe and MEA Culture Test for Healthcare-associated Infections Market Value Share Analysis, by Tissue, 2023 and 2034

Figure 61: Europe and MEA Culture Test for Healthcare-associated Infections Market Value (US$ Mn), by Others, 2020-2034

Figure 62: Europe and MEA Culture Test for Healthcare-associated Infections Market Value Share Analysis, by Others, 2023 and 2034

Figure 63: Europe and MEA Culture Test for Healthcare-associated Infections Market Value (US$ Mn) Share Analysis, by End-user, 2023 and 2034

Figure 64: Europe and MEA Culture Test for Healthcare-associated Infections Market Share Analysis, by End-user, 2023

Figure 65: Europe and MEA Culture Test for Healthcare-associated Infections Market Share Analysis, by End-user, 2034

Figure 66: Europe and MEA Culture Test for Healthcare-associated Infections Market Attractiveness Analysis, by End-user, 2024-2034

Figure 67: Europe and MEA Culture Test for Healthcare-associated Infections Market Value (US$ Mn), by Hospitals & Clinics, 2020-2034

Figure 68: Europe and MEA Culture Test for Healthcare-associated Infections Market Value Share Analysis, by Hospitals & Clinics, 2023 and 2034

Figure 69: Europe and MEA Culture Test for Healthcare-associated Infections Market Value (US$ Mn), by Nursing Homes, 2020-2034

Figure 70: Europe and MEA Culture Test for Healthcare-associated Infections Market Value Share Analysis, by Nursing Homes, 2023 and 2034

Figure 71: Europe and MEA Culture Test for Healthcare-associated Infections Market Value (US$ Mn), by Ambulatory Surgical Centers, 2020-2034

Figure 72: Europe and MEA Culture Test for Healthcare-associated Infections Market Value Share Analysis, by Ambulatory Surgical Centers, 2023 and 2034

Figure 73: Europe and MEA Culture Test for Healthcare-associated Infections Market Value (US$ Mn), by Others, 2020-2034

Figure 74: Europe and MEA Culture Test for Healthcare-associated Infections Market Value Share Analysis, by Others, 2023 and 2034

Figure 75: Europe and MEA Culture Test for Healthcare-associated Infections Market Value Share Analysis, by Region, 2023 and 2034

Figure 76: Europe and MEA Culture Test for Healthcare-associated Infections Market Share Analysis, by Region, 2023

Figure 77: Europe and MEA Culture Test for Healthcare-associated Infections Market Share Analysis, by Region, 2034

Figure 78: Europe Culture Test for Healthcare-associated Infections Market Value (US$ Mn) Share Analysis, by Country / Sub-region, 2023 and 2034

Figure 79: Europe Culture Test for Healthcare-associated Infections Market Attractiveness Analysis, by Country / Sub-region, 2024-2034

Figure 80: Europe Culture Test for Healthcare-associated Infections Market Value (US$ Mn) Share Analysis, by Product, 2023 and 2034

Figure 81: Europe Culture Test for Healthcare-associated Infections Market Attractiveness Analysis, by Product, 2024-2034

Figure 82: Europe Culture Test for Healthcare-associated Infections Market Value (US$ Mn) Share Analysis, by Application, 2023 and 2034

Figure 83: Europe Culture Test for Healthcare-associated Infections Market Attractiveness Analysis, by Application, 2024-2034

Figure 84: Europe Culture Test for Healthcare-associated Infections Market Value (US$ Mn) Share Analysis, by Target Area, 2023 and 2034

Figure 85: Europe Culture Test for Healthcare-associated Infections Market Attractiveness Analysis, by Target Area, 2024-2034

Figure 86: Europe Culture Test for Healthcare-associated Infections Market Value (US$ Mn) Share Analysis, by Sample Type, 2023 and 2034

Figure 87: Europe Culture Test for Healthcare-associated Infections Market Attractiveness Analysis, by Sample Type, 2024-2034

Figure 88: Europe Culture Test for Healthcare-associated Infections Market Value (US$ Mn) Share Analysis, by End-user, 2023 and 2034

Figure 89: Europe Culture Test for Healthcare-associated Infections Market Attractiveness Analysis, by End-user, 2024-2034

Figure 90: Germany Culture Test for Healthcare-associated Infections Market Value (US$ Mn) Share Analysis, by Product, 2023 and 2034

Figure 91: Germany Culture Test for Healthcare-associated Infections Market Attractiveness Analysis, by Product, 2024-2034

Figure 92: Germany Culture Test for Healthcare-associated Infections Market Value (US$ Mn) Share Analysis, by Application, 2023 and 2034

Figure 93: Germany Culture Test for Healthcare-associated Infections Market Attractiveness Analysis, by Application, 2024-2034

Figure 94: Germany Culture Test for Healthcare-associated Infections Market Value (US$ Mn) Share Analysis, by Target Area, 2023 and 2034

Figure 95: Germany Culture Test for Healthcare-associated Infections Market Attractiveness Analysis, by Target Area, 2024-2034

Figure 96: Germany Culture Test for Healthcare-associated Infections Market Value (US$ Mn) Share Analysis, by Sample Type, 2023 and 2034

Figure 97: Germany Culture Test for Healthcare-associated Infections Market Attractiveness Analysis, by Sample Type, 2024-2034

Figure 98: Germany Culture Test for Healthcare-associated Infections Market Value (US$ Mn) Share Analysis, by End-user, 2023 and 2034

Figure 99: Germany Culture Test for Healthcare-associated Infections Market Attractiveness Analysis, by End-user, 2024-2034

Figure 100: U.K. Culture Test for Healthcare-associated Infections Market Value (US$ Mn) Share Analysis, by Product, 2023 and 2034

Figure 101: U.K. Culture Test for Healthcare-associated Infections Market Attractiveness Analysis, by Product, 2024-2034

Figure 102: U.K. Culture Test for Healthcare-associated Infections Market Value (US$ Mn) Share Analysis, by Application, 2023 and 2034

Figure 103: U.K. Culture Test for Healthcare-associated Infections Market Attractiveness Analysis, by Application, 2024-2034

Figure 104: U.K. Culture Test for Healthcare-associated Infections Market Value (US$ Mn) Share Analysis, by Target Area, 2023 and 2034

Figure 105: U.K. Culture Test for Healthcare-associated Infections Market Attractiveness Analysis, by Target Area, 2024-2034

Figure 106: U.K. Culture Test for Healthcare-associated Infections Market Value (US$ Mn) Share Analysis, by Sample Type, 2023 and 2034

Figure 107: U.K. Culture Test for Healthcare-associated Infections Market Attractiveness Analysis, by Sample Type, 2024-2034

Figure 108: U.K. Culture Test for Healthcare-associated Infections Market Value (US$ Mn) Share Analysis, by End-user, 2023 and 2034

Figure 109: U.K. Culture Test for Healthcare-associated Infections Market Attractiveness Analysis, by End-user, 2024-2034

Figure 110: France Culture Test for Healthcare-associated Infections Market Value (US$ Mn) Share Analysis, by Product, 2023 and 2034

Figure 111: France Culture Test for Healthcare-associated Infections Market Attractiveness Analysis, by Product, 2024-2034

Figure 112: France Culture Test for Healthcare-associated Infections Market Value (US$ Mn) Share Analysis, by Application, 2023 and 2034

Figure 113: France Culture Test for Healthcare-associated Infections Market Attractiveness Analysis, by Application, 2024-2034

Figure 114: France Culture Test for Healthcare-associated Infections Market Value (US$ Mn) Share Analysis, by Target Area, 2023 and 2034

Figure 115: France Culture Test for Healthcare-associated Infections Market Attractiveness Analysis, by Target Area, 2024-2034

Figure 116: France Culture Test for Healthcare-associated Infections Market Value (US$ Mn) Share Analysis, by Sample Type, 2023 and 2034

Figure 117: France Culture Test for Healthcare-associated Infections Market Attractiveness Analysis, by Sample Type, 2024-2034

Figure 118: France Culture Test for Healthcare-associated Infections Market Value (US$ Mn) Share Analysis, by End-user, 2023 and 2034

Figure 119: France Culture Test for Healthcare-associated Infections Market Attractiveness Analysis, by End-user, 2024-2034

Figure 120: Italy Culture Test for Healthcare-associated Infections Market Value (US$ Mn) Share Analysis, by Product, 2023 and 2034

Figure 121: Italy Culture Test for Healthcare-associated Infections Market Attractiveness Analysis, by Product, 2024-2034

Figure 122: Italy Culture Test for Healthcare-associated Infections Market Value (US$ Mn) Share Analysis, by Application, 2023 and 2034

Figure 123: Italy Culture Test for Healthcare-associated Infections Market Attractiveness Analysis, by Application, 2024-2034

Figure 124: Italy Culture Test for Healthcare-associated Infections Market Value (US$ Mn) Share Analysis, by Target Area, 2023 and 2034

Figure 125: Italy Culture Test for Healthcare-associated Infections Market Attractiveness Analysis, by Target Area, 2024-2034

Figure 126: Italy Culture Test for Healthcare-associated Infections Market Value (US$ Mn) Share Analysis, by Sample Type, 2023 and 2034

Figure 127: Italy Culture Test for Healthcare-associated Infections Market Attractiveness Analysis, by Sample Type, 2024-2034

Figure 128: Italy Culture Test for Healthcare-associated Infections Market Value (US$ Mn) Share Analysis, by End-user, 2023 and 2034

Figure 129: Italy Culture Test for Healthcare-associated Infections Market Attractiveness Analysis, by End-user, 2024-2034

Figure 130: Spain Culture Test for Healthcare-associated Infections Market Value (US$ Mn) Share Analysis, by Product, 2023 and 2034

Figure 131: Spain Culture Test for Healthcare-associated Infections Market Attractiveness Analysis, by Product, 2024-2034

Figure 132: Spain Culture Test for Healthcare-associated Infections Market Value (US$ Mn) Share Analysis, by Application, 2023 and 2034

Figure 133: Spain Culture Test for Healthcare-associated Infections Market Attractiveness Analysis, by Application, 2024-2034

Figure 134: Spain Culture Test for Healthcare-associated Infections Market Value (US$ Mn) Share Analysis, by Target Area, 2023 and 2034

Figure 135: Spain Culture Test for Healthcare-associated Infections Market Attractiveness Analysis, by Target Area, 2024-2034

Figure 136: Spain Culture Test for Healthcare-associated Infections Market Value (US$ Mn) Share Analysis, by Sample Type, 2023 and 2034

Figure 137: Spain Culture Test for Healthcare-associated Infections Market Attractiveness Analysis, by Sample Type, 2024-2034

Figure 138: Spain Culture Test for Healthcare-associated Infections Market Value (US$ Mn) Share Analysis, by End-user, 2023 and 2034

Figure 139: Spain Culture Test for Healthcare-associated Infections Market Attractiveness Analysis, by End-user, 2024-2034

Figure 140: Switzerland Culture Test for Healthcare-associated Infections Market Value (US$ Mn) Share Analysis, by Product, 2023 and 2034

Figure 141: Switzerland Culture Test for Healthcare-associated Infections Market Attractiveness Analysis, by Product, 2024-2034

Figure 142: Switzerland Culture Test for Healthcare-associated Infections Market Value (US$ Mn) Share Analysis, by Application, 2023 and 2034

Figure 143: Switzerland Culture Test for Healthcare-associated Infections Market Attractiveness Analysis, by Application, 2024-2034

Figure 144: Switzerland Culture Test for Healthcare-associated Infections Market Value (US$ Mn) Share Analysis, by Target Area, 2023 and 2034

Figure 145: Switzerland Culture Test for Healthcare-associated Infections Market Attractiveness Analysis, by Target Area, 2024-2034

Figure 146: Switzerland Culture Test for Healthcare-associated Infections Market Value (US$ Mn) Share Analysis, by Sample Type, 2023 and 2034

Figure 147: Switzerland Culture Test for Healthcare-associated Infections Market Attractiveness Analysis, by Sample Type, 2024-2034

Figure 148: Switzerland Culture Test for Healthcare-associated Infections Market Value (US$ Mn) Share Analysis, by End-user, 2023 and 2034

Figure 149: Switzerland Culture Test for Healthcare-associated Infections Market Attractiveness Analysis, by End-user, 2024-2034

Figure 150: Netherlands Culture Test for Healthcare-associated Infections Market Value (US$ Mn) Share Analysis, by Product, 2023 and 2034

Figure 151: Netherlands Culture Test for Healthcare-associated Infections Market Attractiveness Analysis, by Product, 2024-2034

Figure 152: Netherlands Culture Test for Healthcare-associated Infections Market Value (US$ Mn) Share Analysis, by Application, 2023 and 2034

Figure 153: Netherlands Culture Test for Healthcare-associated Infections Market Attractiveness Analysis, by Application, 2024-2034

Figure 154: Netherlands Culture Test for Healthcare-associated Infections Market Value (US$ Mn) Share Analysis, by Target Area, 2023 and 2034

Figure 155: Netherlands Culture Test for Healthcare-associated Infections Market Attractiveness Analysis, by Target Area, 2024-2034

Figure 156: Netherlands Culture Test for Healthcare-associated Infections Market Value (US$ Mn) Share Analysis, by Sample Type, 2023 and 2034

Figure 157: Netherlands Culture Test for Healthcare-associated Infections Market Attractiveness Analysis, by Sample Type, 2024-2034

Figure 158: Netherlands Culture Test for Healthcare-associated Infections Market Value (US$ Mn) Share Analysis, by End-user, 2023 and 2034

Figure 159: Netherlands Culture Test for Healthcare-associated Infections Market Attractiveness Analysis, by End-user, 2024-2034

Figure 160: Rest of Europe Culture Test for Healthcare-associated Infections Market Value (US$ Mn) Share Analysis, by Product, 2023 and 2034

Figure 161: Rest of Europe Culture Test for Healthcare-associated Infections Market Attractiveness Analysis, by Product, 2024-2034

Figure 162: Rest of Europe Culture Test for Healthcare-associated Infections Market Value (US$ Mn) Share Analysis, by Application, 2023 and 2034

Figure 163: Rest of Europe Culture Test for Healthcare-associated Infections Market Attractiveness Analysis, by Application, 2024-2034

Figure 164: Rest of Europe Culture Test for Healthcare-associated Infections Market Value (US$ Mn) Share Analysis, by Target Area, 2023 and 2034

Figure 165: Rest of Europe Culture Test for Healthcare-associated Infections Market Attractiveness Analysis, by Target Area, 2024-2034

Figure 166: Rest of Europe Culture Test for Healthcare-associated Infections Market Value (US$ Mn) Share Analysis, by Sample Type, 2023 and 2034

Figure 167: Rest of Europe Culture Test for Healthcare-associated Infections Market Attractiveness Analysis, by Sample Type, 2024-2034

Figure 168: Rest of Europe Culture Test for Healthcare-associated Infections Market Value (US$ Mn) Share Analysis, by End-user, 2023 and 2034

Figure 169: Rest of Europe Culture Test for Healthcare-associated Infections Market Attractiveness Analysis, by End-user, 2024-2034

Figure 170: Middle East and Africa Culture Test for Healthcare-associated Infections Market Value (US$ Mn) Share Analysis, by Country, 2023 and 2034

Figure 171: Middle East and Africa Culture Test for Healthcare-associated Infections Market Attractiveness Analysis, by Country, 2024-2034

Figure 172: Middle East and Africa Culture Test for Healthcare-associated Infections Market Value (US$ Mn) Share Analysis, by Product, 2023 and 2034

Figure 173: Middle East and Africa Culture Test for Healthcare-associated Infections Market Attractiveness Analysis, by Product, 2024-2034

Figure 174: Middle East and Africa Culture Test for Healthcare-associated Infections Market Value (US$ Mn) Share Analysis, by Application, 2023 and 2034

Figure 175: Middle East and Africa Culture Test for Healthcare-associated Infections Market Attractiveness Analysis, by Application, 2024-2034

Figure 176: Middle East and Africa Culture Test for Healthcare-associated Infections Market Value (US$ Mn) Share Analysis, by Target Area, 2023 and 2034

Figure 177: Middle East and Africa Culture Test for Healthcare-associated Infections Market Attractiveness Analysis, by Target Area, 2024-2034

Figure 178: Middle East and Africa Culture Test for Healthcare-associated Infections Market Value (US$ Mn) Share Analysis, by Sample Type, 2023 and 2034

Figure 179: Middle East and Africa Culture Test for Healthcare-associated Infections Market Attractiveness Analysis, by Sample Type, 2024-2034

Figure 180: Middle East and Africa Culture Test for Healthcare-associated Infections Market Value (US$ Mn) Share Analysis, by End-user, 2023 and 2034

Figure 181: Middle East and Africa Culture Test for Healthcare-associated Infections Market Attractiveness Analysis, by End-user, 2024-2034

Figure 182: Saudi Arabia Culture Test for Healthcare-associated Infections Market Value (US$ Mn) Share Analysis, by Product, 2023 and 2034

Figure 183: Saudi Arabia Culture Test for Healthcare-associated Infections Market Attractiveness Analysis, by Product, 2024-2034

Figure 184: Saudi Arabia Culture Test for Healthcare-associated Infections Market Value (US$ Mn) Share Analysis, by Application, 2023 and 2034

Figure 185: Saudi Arabia Culture Test for Healthcare-associated Infections Market Attractiveness Analysis, by Application, 2024-2034

Figure 186: Saudi Arabia Culture Test for Healthcare-associated Infections Market Value (US$ Mn) Share Analysis, by Target Area, 2023 and 2034

Figure 187: Saudi Arabia Culture Test for Healthcare-associated Infections Market Attractiveness Analysis, by Target Area, 2024-2034

Figure 188: Saudi Arabia Culture Test for Healthcare-associated Infections Market Value (US$ Mn) Share Analysis, by Sample Type, 2023 and 2034

Figure 189: Saudi Arabia Culture Test for Healthcare-associated Infections Market Attractiveness Analysis, by Sample Type, 2024-2034

Figure 190: Saudi Arabia Culture Test for Healthcare-associated Infections Market Value (US$ Mn) Share Analysis, by End-user, 2023 and 2034

Figure 191: Saudi Arabia Culture Test for Healthcare-associated Infections Market Attractiveness Analysis, by End-user, 2024-2034

Figure 192: UAE Culture Test for Healthcare-associated Infections Market Value (US$ Mn) Share Analysis, by Product, 2023 and 2034

Figure 193: UAE Culture Test for Healthcare-associated Infections Market Attractiveness Analysis, by Product, 2024-2034

Figure 194: UAE Culture Test for Healthcare-associated Infections Market Value (US$ Mn) Share Analysis, by Application, 2023 and 2034

Figure 195: UAE Culture Test for Healthcare-associated Infections Market Attractiveness Analysis, by Application, 2024-2034

Figure 196: UAE Culture Test for Healthcare-associated Infections Market Value (US$ Mn) Share Analysis, by Target Area, 2023 and 2034

Figure 197: UAE Culture Test for Healthcare-associated Infections Market Attractiveness Analysis, by Target Area, 2024-2034

Figure 198: UAE Culture Test for Healthcare-associated Infections Market Value (US$ Mn) Share Analysis, by Sample Type, 2023 and 2034

Figure 199: UAE Culture Test for Healthcare-associated Infections Market Attractiveness Analysis, by Sample Type, 2024-2034

Figure 200: UAE Culture Test for Healthcare-associated Infections Market Value (US$ Mn) Share Analysis, by End-user, 2023 and 2034

Figure 201: UAE Culture Test for Healthcare-associated Infections Market Attractiveness Analysis, by End-user, 2024-2034

Figure 202: South Africa Culture Test for Healthcare-associated Infections Market Value (US$ Mn) Share Analysis, by Product, 2023 and 2034

Figure 203: South Africa Culture Test for Healthcare-associated Infections Market Attractiveness Analysis, by Product, 2024-2034

Figure 204: South Africa Culture Test for Healthcare-associated Infections Market Value (US$ Mn) Share Analysis, by Application, 2023 and 2034

Figure 205: South Africa Culture Test for Healthcare-associated Infections Market Attractiveness Analysis, by Application, 2024-2034

Figure 206: South Africa Culture Test for Healthcare-associated Infections Market Value (US$ Mn) Share Analysis, by Target Area, 2023 and 2034

Figure 207: South Africa Culture Test for Healthcare-associated Infections Market Attractiveness Analysis, by Target Area, 2024-2034

Figure 208: South Africa Culture Test for Healthcare-associated Infections Market Value (US$ Mn) Share Analysis, by Sample Type, 2023 and 2034

Figure 209: South Africa Culture Test for Healthcare-associated Infections Market Attractiveness Analysis, by Sample Type, 2024-2034

Figure 210: South Africa Culture Test for Healthcare-associated Infections Market Value (US$ Mn) Share Analysis, by End-user, 2023 and 2034

Figure 211: South Africa Culture Test for Healthcare-associated Infections Market Attractiveness Analysis, by End-user, 2024-2034

Figure 212: Turkey Culture Test for Healthcare-associated Infections Market Value (US$ Mn) Share Analysis, by Product, 2023 and 2034

Figure 213: Turkey Culture Test for Healthcare-associated Infections Market Attractiveness Analysis, by Product, 2024-2034

Figure 214: Turkey Culture Test for Healthcare-associated Infections Market Value (US$ Mn) Share Analysis, by Application, 2023 and 2034

Figure 215: Turkey Culture Test for Healthcare-associated Infections Market Attractiveness Analysis, by Application, 2024-2034

Figure 216: Turkey Culture Test for Healthcare-associated Infections Market Value (US$ Mn) Share Analysis, by Target Area, 2023 and 2034

Figure 217: Turkey Culture Test for Healthcare-associated Infections Market Attractiveness Analysis, by Target Area, 2024-2034

Figure 218: Turkey Culture Test for Healthcare-associated Infections Market Value (US$ Mn) Share Analysis, by Sample Type, 2023 and 2034

Figure 219: Turkey Culture Test for Healthcare-associated Infections Market Attractiveness Analysis, by Sample Type, 2024-2034

Figure 220: Turkey Culture Test for Healthcare-associated Infections Market Value (US$ Mn) Share Analysis, by End-user, 2023 and 2034

Figure 221: Turkey Culture Test for Healthcare-associated Infections Market Attractiveness Analysis, by End-user, 2024-2034

Figure 222: Egypt Culture Test for Healthcare-associated Infections Market Value (US$ Mn) Share Analysis, by Product, 2023 and 2034

Figure 223: Egypt Culture Test for Healthcare-associated Infections Market Attractiveness Analysis, by Product, 2024-2034

Figure 224: Egypt Culture Test for Healthcare-associated Infections Market Value (US$ Mn) Share Analysis, by Application, 2023 and 2034

Figure 225: Egypt Culture Test for Healthcare-associated Infections Market Attractiveness Analysis, by Application, 2024-2034

Figure 226: Egypt Culture Test for Healthcare-associated Infections Market Value (US$ Mn) Share Analysis, by Target Area, 2023 and 2034

Figure 227: Egypt Culture Test for Healthcare-associated Infections Market Attractiveness Analysis, by Target Area, 2024-2034

Figure 228: Egypt Culture Test for Healthcare-associated Infections Market Value (US$ Mn) Share Analysis, by Sample Type, 2023 and 2034

Figure 229: Egypt Culture Test for Healthcare-associated Infections Market Attractiveness Analysis, by Sample Type, 2024-2034

Figure 230: Egypt Culture Test for Healthcare-associated Infections Market Value (US$ Mn) Share Analysis, by End-user, 2023 and 2034

Figure 231: Egypt Culture Test for Healthcare-associated Infections Market Attractiveness Analysis, by End-user, 2024-2034

Figure 232: Israel Culture Test for Healthcare-associated Infections Market Value (US$ Mn) Share Analysis, by Product, 2023 and 2034

Figure 233: Israel Culture Test for Healthcare-associated Infections Market Attractiveness Analysis, by Product, 2024-2034

Figure 234: Israel Culture Test for Healthcare-associated Infections Market Value (US$ Mn) Share Analysis, by Application, 2023 and 2034

Figure 235: Israel Culture Test for Healthcare-associated Infections Market Attractiveness Analysis, by Application, 2024-2034

Figure 236: Israel Culture Test for Healthcare-associated Infections Market Value (US$ Mn) Share Analysis, by Target Area, 2023 and 2034

Figure 237: Israel Culture Test for Healthcare-associated Infections Market Attractiveness Analysis, by Target Area, 2024-2034

Figure 238: Israel Culture Test for Healthcare-associated Infections Market Value (US$ Mn) Share Analysis, by Sample Type, 2023 and 2034

Figure 239: Israel Culture Test for Healthcare-associated Infections Market Attractiveness Analysis, by Sample Type, 2024-2034

Figure 240: Israel Culture Test for Healthcare-associated Infections Market Value (US$ Mn) Share Analysis, by End-user, 2023 and 2034

Figure 241: Israel Culture Test for Healthcare-associated Infections Market Attractiveness Analysis, by End-user, 2024-2034

Figure 242: Rest of MEA Culture Test for Healthcare-associated Infections Market Value (US$ Mn) Share Analysis, by Product, 2023 and 2034

Figure 243: Rest of MEA Culture Test for Healthcare-associated Infections Market Attractiveness Analysis, by Product, 2024-2034

Figure 244: Rest of MEA Culture Test for Healthcare-associated Infections Market Value (US$ Mn) Share Analysis, by Application, 2023 and 2034

Figure 245: Rest of MEA Culture Test for Healthcare-associated Infections Market Attractiveness Analysis, by Application, 2024-2034

Figure 246: Rest of MEA Culture Test for Healthcare-associated Infections Market Value (US$ Mn) Share Analysis, by Target Area, 2023 and 2034

Figure 247: Rest of MEA Culture Test for Healthcare-associated Infections Market Attractiveness Analysis, by Target Area, 2024-2034

Figure 248: Rest of MEA Culture Test for Healthcare-associated Infections Market Value (US$ Mn) Share Analysis, by Sample Type, 2023 and 2034

Figure 249: Rest of MEA Culture Test for Healthcare-associated Infections Market Attractiveness Analysis, by Sample Type, 2024-2034

Figure 250: Rest of MEA Culture Test for Healthcare-associated Infections Market Value (US$ Mn) Share Analysis, by End-user, 2023 and 2034

Figure 251: Rest of MEA Culture Test for Healthcare-associated Infections Market Attractiveness Analysis, by End-user, 2024-2034

TMRGL86426
December 2024
420 Pages
PPT, Excel, PDF

- Get Started -

Get insights that lead to new growth opportunities

Buy Now

Get answers to your queries on this report from our experts

- Want to customize this report? -

We offer 100% Free Customization at the time of purchase

An adaptive Approach to Modern Day Research needs

Industry Verticals »

Insights »

About TMR »

Reports